摘要
端粒酶是一种核糖酶,对真核细胞DNA端粒的合成有重要作用。端粒可以产生永生化和人体细胞恶性转化,因此必须仔细观察端粒酶活性在多数肿瘤细胞的一个重要表现。使用不同治疗的药物对正常细胞无任何副作用,可以抑制癌细胞或诱导凋亡,抑制增殖。天然产物具有抗肿瘤作用,如从植物中得到的那些可能是合适的备选药物,由于它们相对于大多数化疗药物,在防止一些副作用发生和抵抗肿瘤方面的能力。在这方面,许多研究表明天然植物化学物质,通过影响其亚基组成对端粒酶活性有抑制作用。因此,本文的目的是对这些种类的植物化学物质的性质和机制方面进行研究。此外,提高植物化学物质疗效的包括如联合治疗和纳米药物制剂为基础的方法
关键词: 治疗癌症;植物化学;Telomerase。
Current Medicinal Chemistry
Title:An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity
Volume: 23 Issue: 22
Author(s): Abbas Alibakhshi, Javad Ranjbari, Yones Pilehvar-Soltanahmadi, Marzieh Nasiri, Mahdie Mollazade, Nosratollah Zarghami
Affiliation:
关键词: 治疗癌症;植物化学;Telomerase。
摘要: Telomerase is a ribonucleoprotein enzyme, which has a significant role in synthesizing DNA telomeric in eukaryotes. Telomere maintenance can cause to immortalization and malignant transformation of human cells and thereby telomerase activity must be scrutinized as an important factor in most tumor cells. The proliferation of cancer cells or apoptosis induction can be suppressed by telomerase inhibition using different therapeutic agents without any side effects upon normal cells. Natural substances, with anti-tumor effects, such as those derived from plants can be suitable candidates due to their capabilities in preventing some side effects and resistance of tumors with respect to most chemotherapeutic drugs. In this regards, many studies have shown that natural phytochemicals have inhibitory effects on telomerase activity through affecting its subunits and components. Therefore, the aim of this paper is to review the recent studies on these kinds of phytochemicals in terms of property and mechanism. Moreover, strategies for improving the therapeutic efficacy of plant-derived substances such as combination therapy and nanoformulation based approaches are included.
Export Options
About this article
Cite this article as:
Abbas Alibakhshi, Javad Ranjbari, Yones Pilehvar-Soltanahmadi, Marzieh Nasiri, Mahdie Mollazade, Nosratollah Zarghami , An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity, Current Medicinal Chemistry 2016; 23 (22) . https://dx.doi.org/10.2174/0929867323666160425113705
DOI https://dx.doi.org/10.2174/0929867323666160425113705 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Lactosylceramide Synthase (Glucosylceramide β1→4 Galactosyltransferase); Implication as A Drug Target
Current Drug Targets Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews MT1-MMP Modulates bFGF-Induced VEGF-A Expression in Corneal Fibroblasts
Protein & Peptide Letters Synthesis and Biological Evaluations of Organoruthenium Scaffolds: A Comprehensive Update
Current Organic Synthesis Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides
Current HIV Research Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Flexible Bronchoscopy: Importance of Standardization of Practice for the Best Route of Insertion.
Current Respiratory Medicine Reviews Protein Engineering: A New Frontier for Biological Therapeutics
Current Drug Metabolism PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway
Anti-Cancer Agents in Medicinal Chemistry Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
Current Medicinal Chemistry Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
Current Pharmaceutical Design The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Current Pharmaceutical Design Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Current Cancer Drug Targets Triterpenoid Saponins from Two Panax japonicus Varietals Used in Tujia Ethnomedicine
Current Traditional Medicine The Patenting and Technological Trends in Cervical Cancer Therapy
Current Biomarkers (Discontinued) Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma
Current Analytical Chemistry Zn Finger Containing Proteins as Targets for the Control of Viral Infections
Infectious Disorders - Drug Targets